Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
 
  
   
Insider Information:   Rowland Charles A Jr
Relationship:  
City:   Chadds Ford
State:   PA
   
Insider Summary:
  
   
Companies Owned :   8    
Direct Shares   607,545    

Indirect Shares

  0      
Direct Value   $2,180,077    

Indirect Value

  $0      
Total Shares   607,545      
Total Value   $2,180,077      


Endo Health Solutions Inc
 $4 DNIB Upwind Inc
 $0 Viking Therapeutics, Inc.
 $1,560,600 Nabriva Therapeutics AG
 $6,016 Blueprint Medicines Corp
 $613,457 Generation Bio Co.
 $0 Endo Health Solutions Inc
 $4 DNIB Upwind Inc
 $0 Viking Therapeutics, Inc.
 $1,560,600 Nabriva Therapeutics AG
 $6,016 Blueprint Medicines Corp
 $613,457 Generation Bio Co.
 $0
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :

    0   
    3    

     Stock price went up :

    0   
    0    
     Stock price went down :
    0   
    3    
   
     Gain/Loss Ratio :
   0.0   
   -3.0   
     Percentage Gain/Loss :
     0.0%
 -48.6%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Viropharma Inc VPHM VP, Chief Financial Of... 2014-01-24 0 2008-11-03 0    Premium*  
            Endo Health Solutions Inc ENDP EVP, CFO & Treasurer 2008-02-21 6,699 2008-02-21 0    Premium*  
            DNIB Upwind Inc BIND Director 2016-08-26 15,000 2016-08-26 0    Premium*  
            Viking Therapeutics, Inc. VKTX Director 2023-05-16 30,000 2018-05-29 0    Premium*  
            Nabriva Therapeutics AG NBRV Director 2022-08-01 15,277 2018-12-24 0    Premium*  
            Blueprint Medicines Corp BPMC Director 2021-06-02 5,812 2019-06-20 0    Premium*  
            Orchard Therapeutics Plc ORTX 2024-01-24 0 0    Premium*  
            Generation Bio Co. GBIO 2023-12-04 534,757 2020-06-16 0    Premium*  
* Premium Members only  

Records found :    50         Free Registration Required For Full Results.    Limit: 25

Download
  Page 2 of 2
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

 
3m +/-  
Form
VKTX Viking Therapeutics, Inc. Director   –       •      –    2023-05-16 4 AS $25.00 $1,000,000 D/D (40,000) 30,000 0 %
VPHM Viropharma Inc VP, Chief Financial Officer   •       –      –    2012-03-07 4 D $29.49 $374,965 D/D (12,715) 35,048 0 -
VPHM Viropharma Inc VP, Chief Financial Officer   •       –      –    2012-03-07 4 OE $11.96 $374,985 D/D 30,638 47,763 0 -
VPHM Viropharma Inc VP, Chief Financial Officer   •       •      –    2014-01-24 4 A $0.00 $0 D/D 48,878 48,878 0 -
GBIO Generation Bio Co. Director   –       •      –    2020-06-16 4 A $0.00 $0 D/D 50,627 50,627 0 -
NBRV Nabriva Therapeutics AG Director   –       •      –    2018-12-24 4 B $1.31 $69,430 D/D 53,000 53,000 2.39 -
VPHM Viropharma Inc VP, Chief Financial Officer   •       •      –    2013-12-18 4 D $49.74 $1,249,916 D/D (25,129) 60,886 0 -
VPHM Viropharma Inc VP, Chief Financial Officer   •       –      –    2011-03-14 4 OE $5.91 $280,600 D/D 35,000 63,496 0 -
VPHM Viropharma Inc VP, Chief Financial Officer   •       •      –    2013-12-27 4 D $49.86 $35,101 D/D (704) 64,722 0 -
VPHM Viropharma Inc VP, Chief Financial Officer   •       •      –    2013-12-27 4 OE $5.91 $26,831 D/D 4,540 65,426 0 -
VKTX Viking Therapeutics, Inc. Director   –       •      –    2023-05-16 4 OE $1.08 $43,200 D/D 40,000 70,000 0 -
NBRV Nabriva Therapeutics AG Director   –       •      –    2020-07-29 4 A $0.00 $0 D/D 17,500 70,500 0 -
VPHM Viropharma Inc VP, Chief Financial Officer   •       •      –    2013-12-18 4 OE $5.91 $453,673 D/D 49,006 72,721 0 -
GBIO Generation Bio Co. Director   –       •      –    2020-06-16 4 B $19.00 $570,000 D/D 30,000 80,627 2.39 -
VPHM Viropharma Inc VP, Chief Financial Officer   •       •      –    2014-01-08 4 D $49.80 $321,160 D/D (6,449) 87,026 0 -
VPHM Viropharma Inc VP, Chief Financial Officer   •       •      –    2014-01-08 4 OE $5.91 $273,157 D/D 28,753 87,584 0 -
VPHM Viropharma Inc VP, Chief Financial Officer   •       –      –    2012-03-01 4 OE $5.91 $699,200 D/D 70,000 99,875 0 -
GBIO Generation Bio Co.   –       •      –    2021-01-11 4 B $24.50 $499,996 D/D 20,408 101,035 0.01 -
GBIO Generation Bio Co.   –       •      –    2022-09-13 4 B $5.20 $97,752 D/D 18,784 119,819 0.01 -
GBIO Generation Bio Co.   –       •      –    2022-09-14 4 B $5.30 $29,652 D/D 5,600 125,419 0.01 -
GBIO Generation Bio Co.   –       •      –    2022-09-15 4 B $5.41 $92,765 D/D 17,147 142,566 0.01 -
GBIO Generation Bio Co.   –       •      –    2022-09-16 4 B $5.48 $183,476 D/D 33,481 176,047 0.01 -
GBIO Generation Bio Co.   –       •      –    2022-09-19 4 B $5.26 $82,845 D/D 15,750 191,797 0.01 -
GBIO Generation Bio Co.   –       •      –    2023-12-01 4 B $1.31 $252,778 D/D 192,960 384,757 0.01 -
GBIO Generation Bio Co.   –       •      –    2023-12-04 4 B $1.50 $225,000 D/D 150,000 534,757 0.01 -

  50  Records found
  1   2     
  Page 2 of 2  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed